Filed before 2025Filed 1 December 2020
RayzeBio, Inc. raised $105M
RayzeBio, Inc., a biotech company based in San Diego, CA, raised $105M in a new equity round, according to a filing dated 1 December 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 December 2020
- Round
- Equity round
- Amount sold
- $105M
- Offering size
- $105M
- Investors so far
- 17
- Based in
- San Diego, CA
Investors on the board
- Versant
- Versant Vantage
- Hypothesis Studio
- Venrock Healthcare Capital Partners EG
- Venrock Healthcare Capital
- venBio
- Petrichor Scion Therapeutics
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 95% of the 1,744 tracked raises with an amount filed in 2020, and than 91% of the 152 in biotech.
RayzeBio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 22 Sep 2022 | New filing | $168M | Another raise |
| 10 Jun 2021 | New filing | $109M | Another raise |
| 1 Dec 2020 | New filing | $105M | This raise |
| 9 Nov 2020 | New filing | $15M | Another raise |
More with Versant on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.